NCT06432998

Brief Summary

The high incidence of gynecological cancers, together with dyspareunia and vaginal stenosis, some of its most frequent sequelae, create the need to continue studying and researching oncological physiotherapy techniques that treat and prevent these sequelae, in order to preserve and/or improve the quality of life of cancer patients. Therefore, through this study, we sought to verify the effectiveness of oncological perineal massage to treat pain during sexual intercourse and vaginal stenosis. The objective of this study will be to demonstrate the effectiveness of a treatment that will consist of a health education session related to the pelvic floor and the consequences related to cancer along with ten sessions of oncological perineal massage that will be carried out for fifty minutes, once a week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 29, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

May 31, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

May 22, 2024

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain (Visual Analoge Scale)

    Visual Analogical Scale (VAS) is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left "0" (worst) to the right "10"(best)

    Change from baseline at six months

Secondary Outcomes (4)

  • Criteria for Adverse Events (CTCAE)

    Change from baseline at six months

  • Quality of life (EORCT QLQ-C30)

    Change from baseline at six months

  • Female sexual function index

    Change from baseline at six months

  • Likert questionnaire by sexual dysfunction

    Change from baseline at six months

Study Arms (2)

Perineal massage

EXPERIMENTAL

Ten sessions of perineal massage, which will be carried out for fifty minutes, once a week, together with a health education program.

Other: Perineal massage

Treatment with dilators

ACTIVE COMPARATOR

A health education session will be held but then the use of vaginal dilators will be done according to the gold standard treatment.

Other: Standard treatment

Interventions

The technique will be applied for approximately twenty minutes and will be carried out as follows: the vaginal dilator is introduced progressively using crescent-shaped movements. Once the dilator is fully inserted, movements will be made from bottom to top and from one side to the other, and then continue with the crescent-shaped movements.

Perineal massage

The treatment will consist of the use of vaginal dilators according to the gold standard proposed in the literature. It will consist of introducing the same dilators as for the experimental group, with the same time schedule, but without massage, only introducing the dilator and keeping it in the vagina for 20 minutes.

Treatment with dilators

Eligibility Criteria

Age18 Years - 52 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen diagnosed with vaginal stenosis and dyspareunia due to cancer
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women between 18 and 52 years old
  • Oncology patients with a diagnosis of dyspareunia and vaginal stenosis related to treatments.
  • Patients with QT/RT/BT treatment who have a diagnosis of dyspareunia and vaginal stenosis.
  • Patients on hormonal suppressive treatment with a diagnosis of dyspareunia and vaginal stenosis.

You may not qualify if:

  • Patients who do not accept intracavitary treatment.
  • Patients with abdominopelvic surgical treatment prior to oncological process.
  • Patients with a diagnosis of dyspareunia prior to cancer.
  • Patients with vaginal narrowing prior to cancer.
  • Patients with menopause at the time of cancer diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asociación Española Contra el Cáncer en la provincia de Santa cruz de Tenerife.

Santa Cruz de Tenerife, Tenerife, Spain

Location

Related Publications (1)

  • Perez-Garcia R, Abuin-Porras V, Minguez-Esteban I, Pecos-Martin D. Oncological perineal massage in vaginal stenosis and dyspareunia in women with gynecological cancer: a randomized controlled trial. Front Oncol. 2025 Nov 28;15:1680126. doi: 10.3389/fonc.2025.1680126. eCollection 2025.

MeSH Terms

Conditions

Cancer PainHead and Neck Neoplasms

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasms

Study Officials

  • Raquel Perez-García

    Asociación Española Contra el Cáncer en la provincia de Santa cruz de Tenerife.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 22, 2024

First Posted

May 29, 2024

Study Start

May 31, 2024

Primary Completion

December 20, 2025

Study Completion

December 20, 2025

Last Updated

May 1, 2026

Record last verified: 2026-04

Locations